As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: November 19, 2014
by Alzheimer’s Society:
Obesity in healthy older adults may be linked to memory and thinking problems, according to research presented at Neuroscience 2014 in Washington DC today (18 November 2014).
Researchers at the Australian National University in Canberra followed 420 cognitively healthy adults aged 60-64 for eight years. The participants’ body mass index (BMI) was measured at the start of the study, and again after four and eight years. At these times, the participants were also given a brain scan to measure the size of a part of the brain called the hippocampus, which is important for learning and memory.
Having a higher body mass index was found to be associated with a smaller hippocampus, and those with a higher BMI at the start of the research experienced greater shrinkage of the hippocampus during the study.
Dr Doug Brown, Director of Research and Development at Alzheimer’s Society, said:
‘Although this study didn’t look directly at dementia in these participants, the hippocampus is an important area of the brain and is often one of the first areas to be affected in dementia, especially Alzheimer’s disease. Understanding ways to improve the health of this crucial brain region could help us reduce the effects of dementia – more research is needed to see if this is the case.
‘We know that obesity in mid-life is a risk factor for later dementia, so it’s concerning to see it possibly having a direct effect on the brain later in life too. What’s good for your heart is good for your head. The best way to reduce the risk of developing dementia is to eat a healthy diet, take regular exercise, maintain a healthy weight and not smoke.’
Thirty-six million people worldwide suffer from Alzheimer’s disease and dementia. In Canada, 25,000 new cases are diagnosed each year. Those sobering numbers have researchers around the globe racing to come up with new ways to...
he Food and Drug Administration issued new guides on drug development for neurological disorders. This sets the stage for possible treatments for Alzheimer’s. The disease-oriented development guide documents will provide details on how researchers...
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.